- Home
- LPSN vs NSPR Comparison
LPSN vs NSPR Comparison
Compare LPSN & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- NSPR
- Stock Information
- Founded
- LPSN 1995
- NSPR 2005
- Country
- LPSN United States
- NSPR United States
- Employees
- LPSN N/A
- NSPR N/A
- Industry
- LPSN EDP Services
- NSPR Medical/Dental Instruments
- Sector
- LPSN Technology
- NSPR Health Care
- Exchange
- LPSN Nasdaq
- NSPR Nasdaq
- Market Cap
- LPSN 72.8M
- NSPR 79.7M
- IPO Year
- LPSN 2000
- NSPR N/A
- Fundamental
- Price
- LPSN $0.78
- NSPR $2.54
- Analyst Decision
- LPSN Hold
- NSPR Strong Buy
- Analyst Count
- LPSN 3
- NSPR 2
- Target Price
- LPSN $1.20
- NSPR $4.50
- AVG Volume (30 Days)
- LPSN 1.1M
- NSPR 49.1K
- Earning Date
- LPSN 05-07-2025
- NSPR 05-09-2025
- Dividend Yield
- LPSN N/A
- NSPR N/A
- EPS Growth
- LPSN N/A
- NSPR N/A
- EPS
- LPSN N/A
- NSPR N/A
- Revenue
- LPSN $292,025,000.00
- NSPR $7,027,000.00
- Revenue This Year
- LPSN N/A
- NSPR $27.41
- Revenue Next Year
- LPSN $0.43
- NSPR $127.08
- P/E Ratio
- LPSN N/A
- NSPR N/A
- Revenue Growth
- LPSN N/A
- NSPR 8.49
- 52 Week Low
- LPSN $0.52
- NSPR $2.07
- 52 Week High
- LPSN $2.08
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- LPSN 48.59
- NSPR 53.14
- Support Level
- LPSN $0.65
- NSPR $2.42
- Resistance Level
- LPSN $0.80
- NSPR $2.60
- Average True Range (ATR)
- LPSN 0.06
- NSPR 0.14
- MACD
- LPSN -0.00
- NSPR 0.03
- Stochastic Oscillator
- LPSN 46.32
- NSPR 86.67
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.